Archive


Category: ACTIV-2

  • COVID-19 Treatment Trial Reaches Out to Communities of Color

    An ongoing problem in clinical trials over the years has been a failure to procure diverse enough representation among the participants. For a long time, this was due to bias and oversight on the part of the research community, and the consequence was a lack of full understanding in how medications and treatments affected women […]